AbCellera Biologics Inc.
ABCL
$4.39
$0.092.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -34.73M | -45.62M | -34.21M | -51.11M | -36.93M |
| Total Depreciation and Amortization | 7.06M | 6.61M | -18.10M | 38.30M | 38.04M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.06M | 17.00M | 29.41M | -10.34M | -23.04M |
| Change in Net Operating Assets | -16.80M | 10.46M | 14.90M | -5.73M | -8.04M |
| Cash from Operations | -32.40M | -11.55M | -8.00M | -28.88M | -29.97M |
| Capital Expenditure | -13.37M | -10.64M | -15.63M | -18.52M | -20.11M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -18.45M | 18.57M | 51.33M | 22.21M | 72.21M |
| Cash from Investing | -31.81M | 7.94M | 35.70M | 3.70M | 52.10M |
| Total Debt Issued | 5.51M | 6.15M | 5.90M | 3.10M | 2.83M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 227.00K | -- |
| Repurchase of Common Stock | -- | -- | -1.58M | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.88M | -178.00K | -177.00K | -184.00K | -183.00K |
| Cash from Financing | -3.38M | 5.97M | 4.14M | 3.15M | 2.65M |
| Foreign Exchange rate Adjustments | 761.00K | 590.00K | -2.16M | 367.00K | -43.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -66.83M | 2.94M | 29.69M | -21.67M | 24.74M |